Hallucinogen abuse with hallucinogen-induced anxiety disorder
ICD-10 F16.180 is a billable code used to indicate a diagnosis of hallucinogen abuse with hallucinogen-induced anxiety disorder.
Hallucinogen abuse with hallucinogen-induced anxiety disorder refers to a pattern of hallucinogen use that leads to significant impairment or distress, characterized by the development of anxiety symptoms directly attributable to the use of hallucinogenic substances. Hallucinogens, such as LSD, psilocybin, and mescaline, can induce profound alterations in perception, mood, and cognitive processes. When abused, these substances can lead to acute anxiety episodes, panic attacks, and persistent anxiety disorders. The diagnosis requires evidence of substance use leading to anxiety symptoms that are not better explained by other mental health conditions. Clinicians must assess the severity of the anxiety, the frequency and quantity of hallucinogen use, and any co-occurring mental health disorders. Treatment often involves a combination of psychotherapy, such as cognitive-behavioral therapy (CBT), and pharmacotherapy to manage anxiety symptoms. Understanding the interplay between substance use and mental health is crucial for effective intervention.
Detailed patient history, including substance use patterns and mental health evaluations.
Patients presenting with anxiety symptoms following hallucinogen use.
Consideration of co-occurring disorders and the need for a multidisciplinary approach.
Comprehensive substance use assessments and treatment plans.
Patients in withdrawal or experiencing anxiety due to hallucinogen abuse.
Focus on harm reduction strategies and long-term recovery planning.
Used for follow-up visits for patients with hallucinogen-induced anxiety.
Document the patient's history, current symptoms, and treatment plan.
Psychiatry may require more detailed mental status examinations.
Hallucinogen abuse refers to the harmful use of hallucinogens without meeting criteria for dependence, while dependence includes a pattern of use leading to tolerance, withdrawal, and significant impairment.
